1. Hoffbrand AV. Petit JE. Moss PAH. Hematologi. 4th. Jakarta: EGC; 2005.

p:167-176
2. Besa EC. Chronic myelogenous leukemia. Medscape: 2014.
3. Chen YB. Chronic myelogenous leukemia. Medlineplus: 2014
4. Price SA. Wilson LM. Patofisiologi. Konsep klinis proses-proses penyakit.
Vol.1. 6th . Jakarta: EGC; 2006. P:277-281
5. Khrisnan K. Leukemia chronic myeloid. American cancer association: 2014
6. Cardama AQ. Cortes JE. Chronic myeloid leukemia (diagnosis and treatment).
Symposium oncology practice: 2006
7. Alenzy FQ. Wyse RK. A close link between Fas, p53 and Apaf1 in chronic
myeloid leukemia. Vol.28. Saudi med journal: 2007
8. Melo JV. Barnes DJ. Chronic myeloid leukemia as a model of disesase
evolution in human cancer. Vol.7. Nature publishing group: 2007
9. Sawyers CL. Chronic myeloid leukemia. Vol.340. The new England journal of
medicine: 1999
10. Saglio G. Kim DW. Issaragrisil S. Nilotinib vs imatinib for newly diagnose
chronic myeloid leukemia. NEJM: 2010
11. Alberta health service. Management of chronic myeloid leukemia. Clinical
practice guidline Lyhe: 2012
12. Desmukh C. Saikia T. Bakshi A. Imatinib mesylate in chronic myelocytic
leukemia. Vol.53. JAPI: 2005
13. Hoffbrand AV, Pettit JE, Moss PAH. Kapita Selekta Hematologi. Jakarta:
Penerbit Buku kedokteran EGC;2002.p.167-8
14. Bloomfield CD, Byrd JC, Wetzler M. Acute and Chronic Myeloid Leukemia.
In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL,
Loscalzo J; editors. Harrisons Principles of Internal Medicine. 17thed. New
York: McGraw Hill Companies; 2008.
15. Fadjari, Heri. Leukimia Granulositik Kronis in Buku ajar Ilmu Penyakit
dalam. Sudoyo AW, Setiyohadi B, Alwi I et al. Jakarta: Pusat Penerbitan
16.

Departemen Ilmu Penyakit Dalam FKUI. 2006. Hal:689-91

Chronic myelogenous leukemia. Fort Washington,
Comprehensive

Cancer

Pa.:

National
Network.

http://www.nccn.org/professionals/physician_gls/PDF/cml.pdf.
17. Chronic myelogenous leukemia treatment (PDQ). National Cancer Institute.
http://www.cancer.gov/cancertopics/pdq/treatment/CML/patient/allpages.
Accessed Sept. 15, 2010.

18. Kantarjian HM, Talpaz M. Chronic myelogenous leukemia. Hematol Oncol

Clin N Am. Jun 2004;18(3):XV-XVI
19. Moreb J, Johnson T, Kubilis P, Myers L, Oblon D, Miller A, et al. Improved
survival of patients with chronic myelogenous leukemia undergoing
allogeneic bone marrow transplantation. Am J Hematol. Dec 1995;50(4):3046.
20. Behrman R. Kliegman R. Jenson H. Nelson Textbook of Pediatrics. 2000; 16th
edition : (501) 1537 1540
21. Voute P. Kalifa C. Barrett A. Cancer in Children Clinical Management. 1998;
4th edition : (4) 44 57
22. Haskell C. Cancer Treatment. 1985; 2nd edition : (5) 43 9
23. Bagemann, Rastetter J. Atlas of Acute Leukemia. In Clinical Hematology rded.
Thieme, Stuttgart. 1986 pp 243-48.
24. Berg SL, Steuber CP, Poplack DG. Clinical Manifestation of Acute
Lymphoblastic Leukemia. In Hoffman ed : Hematology : Basic Principles and
Practice 3rd ed. Churchill Livingstone Inc. 2000, pp 1070-76